Alaunos Therapeutics Inc. (NASDAQ: TCRT)
$1.9700
-0.0500 ( -2.48% ) 3.3K
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
Market Data
Open
$1.9700
Previous close
$2.0200
Volume
3.3K
Market cap
$3.19M
Day range
$1.9200 - $2.0300
52 week range
$1.6300 - $32.8500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 40 | Nov 14, 2024 |
| 8-k | 8K-related | 11 | Oct 10, 2024 |
| 4 | Insider transactions | 1 | Aug 16, 2024 |
| 4 | Insider transactions | 1 | Aug 16, 2024 |
| 10-q | Quarterly Reports | 40 | Aug 14, 2024 |
| 8-k/a | 8K-related | 12 | Jul 17, 2024 |
| 8-k/a | 8K-related | 12 | Jul 17, 2024 |
| 8-k | 8K-related | 12 | Jul 16, 2024 |
| 8-k | 8K-related | 12 | Jul 16, 2024 |
| 8-k | 8K-related | 13 | Jun 21, 2024 |